-
Cerner Trading Lower; CEO Confirms Ongoing Cancer Treatment
Monday, January 25, 2016 - 3:15pm | 189Read More...Shares of Cerner Corporation (NASDAQ: CERN) were trading lower by more than 1 percent on Monday after the company's CEO disclosed in a letter to clients, shareholders and colleagues he has been diagnosed with a soft tissue cancer. Cerner's CEO, Neal Patterson, said in a letter he was...

